Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
531
-
Total shares
-
219M
-
Shares change
-
+566K
-
Total reported value, excl. options
-
$26.8B
-
Value change
-
+$69.3M
-
Put/Call ratio
-
0.91
-
Number of buys
-
251
-
Number of sells
-
-257
-
Price
-
$122.35
Significant Holders of ALEXION PHARMACEUTICALS INC - COM (ALXN) as of Q4 2016
569 filings reported holding ALXN - ALEXION PHARMACEUTICALS INC - COM as of Q4 2016.
ALEXION PHARMACEUTICALS INC - COM (ALXN) has 531 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 219M shares
.
Largest 10 shareholders include FMR LLC (28.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (21.1M shares), VANGUARD GROUP INC (14M shares), STATE STREET CORP (10.6M shares), JENNISON ASSOCIATES LLC (8.28M shares), Capital Research Global Investors (7.29M shares), BAKER BROS. ADVISORS LP (6.54M shares), BlackRock Institutional Trust Company, N.A. (6.09M shares), AMERIPRISE FINANCIAL INC (5.7M shares), and SANDS CAPITAL MANAGEMENT, LLC (5.59M shares).
This table shows the top 531 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.